GLP-1 itself is a gut-derived incretin hormone released by the enteroendocrine cells in response to nutrient intake
Strong healthcare infrastructure, established reimbursement systems, and widespread physician adoption further support market penetration
Late caffeine disrupts sleep quality, which worsens fatigue the next day in a vicious cycle
On August 2 of this year, Jaclyn Bjorklund, a 44-year-old woman from Louisiana, filed a lawsuit against Novo Nordisk, the company behind Ozempic and Wegovy, and Eli Lilly, who make Mounjaro, another GLP-1 drug
Aging- and photoaging-dependent changes of enzymic and nonenzymic antioxidants in the epidermis and dermis of human skin in vivo
GLP-1s make it easier to lose weight, so smaller workouts still move the needle